Why is Windlas Biotech falling/rising?

As of 05-Sep, Windlas Biotech Ltd is currently priced at 987.80, reflecting an increase of 2.35 (0.24%). The stock has shown a positive trend recently, gaining for three consecutive days with a total return of 1.52% during this period. Despite this upward movement, the stock has underperformed the Sensex over the past week, with a decline of 0.30% compared to the benchmark's increase of 1.13%. The company has reported strong financial results, including record net sales and profit before tax, which contribute positively to its valuation. However, the stock's delivery volume has decreased significantly, indicating falling investor participation, which could be a concern for future price stability.
Broader Market Context: In the context of the broader market, Windlas Biotech's recent performance contrasts with the Sensex, which has shown a positive return of 1.13% over the past week. While the stock has outperformed its sector today by 0.31%, its year-to-date performance remains negative at -4.42%, compared to the Sensex's positive return of 3.29%. The stock's long-term growth prospects are tempered by a relatively low operating profit growth rate of 15.08% over the last five years, which raises concerns about its sustainability in the face of a premium valuation compared to peers.